81 related articles for article (PubMed ID: 17368684)
1. Olanzapine treatment decreases the density of muscarinic M2 receptors in the dorsal vagal complex of rats.
Deng C; Weston-Green KL; Han M; Huang XF
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):915-20. PubMed ID: 17368684
[TBL] [Abstract][Full Text] [Related]
2. The effects of antipsychotics on the density of cannabinoid receptors in the dorsal vagal complex of rats: implications for olanzapine-induced weight gain.
Weston-Green K; Huang XF; Han M; Deng C
Int J Neuropsychopharmacol; 2008 Sep; 11(6):827-35. PubMed ID: 18257959
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine-activated AMPK signaling in the dorsal vagal complex is attenuated by histamine H1 receptor agonist in female rats.
He M; Zhang Q; Deng C; Wang H; Huang XF
Endocrinology; 2014 Dec; 155(12):4895-904. PubMed ID: 25264935
[TBL] [Abstract][Full Text] [Related]
4. Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels.
Weston-Green K; Huang XF; Lian J; Deng C
Eur Neuropsychopharmacol; 2012 May; 22(5):364-73. PubMed ID: 21982116
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent effects of olanzapine treatment on the expression of histidine decarboxylase, H1 and H3 receptor in the rat brain: The roles in olanzapine-induced obesity.
He M; Zhang Q; Deng C; Jin T; Song X; Wang H; Huang XF
Psychoneuroendocrinology; 2017 Nov; 85():190-199. PubMed ID: 28886461
[TBL] [Abstract][Full Text] [Related]
6. Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression.
Han M; Deng C; Burne TH; Newell KA; Huang XF
Psychoneuroendocrinology; 2008 Jun; 33(5):569-80. PubMed ID: 18358632
[TBL] [Abstract][Full Text] [Related]
7. M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders.
Zavitsanou K; Katsifis A; Yu Y; Huang XF
Brain Res Bull; 2005 May; 65(5):397-403. PubMed ID: 15833594
[TBL] [Abstract][Full Text] [Related]
8. A high n-6 polyunsaturated fatty acid diet reduces muscarinic M2/M4 receptor binding in the rat brain.
du Bois TM; Bell W; Deng C; Huang XF
J Chem Neuroanat; 2005 Jun; 29(4):282-8. PubMed ID: 15927789
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies.
Teaktong T; Piggott MA; Mckeith IG; Perry RH; Ballard CG; Perry EK
Behav Brain Res; 2005 Jun; 161(2):299-305. PubMed ID: 15922057
[TBL] [Abstract][Full Text] [Related]
10. Effects of typical and atypical antipsychotic drugs on rat brain muscarinic receptors.
Zavitsanou K; Nguyen VH; Han M; Huang XF
Neurochem Res; 2007 Mar; 32(3):525-32. PubMed ID: 17268842
[TBL] [Abstract][Full Text] [Related]
11. The role of thermogenesis in antipsychotic drug-induced weight gain.
Stefanidis A; Verty AN; Allen AM; Owens NC; Cowley MA; Oldfield BJ
Obesity (Silver Spring); 2009 Jan; 17(1):16-24. PubMed ID: 19107124
[TBL] [Abstract][Full Text] [Related]
12. Chronic administration of haloperidol and olanzapine attenuates ketamine-induced brain metabolic activation.
Duncan GE; Miyamoto S; Lieberman JA
J Pharmacol Exp Ther; 2003 Jun; 305(3):999-1005. PubMed ID: 12626664
[TBL] [Abstract][Full Text] [Related]
13. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.
Kinon BJ; Basson BR; Gilmore JA; Tollefson GD
J Clin Psychiatry; 2001 Feb; 62(2):92-100. PubMed ID: 11247108
[TBL] [Abstract][Full Text] [Related]
14. Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways.
Sakai K; Gao XM; Hashimoto T; Tamminga CA
Synapse; 2001 Feb; 39(2):152-60. PubMed ID: 11180502
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic treatment of olanzapine and haloperidol on peptide YY binding densities in the rat brain.
Wang Q; Huang XF
Exp Neurol; 2008 Jan; 209(1):261-7. PubMed ID: 18022161
[TBL] [Abstract][Full Text] [Related]
16. The effects of antipsychotic drugs on GABAA receptor binding depend on period of drug treatment and binding site examined.
Skilbeck KJ; O'Reilly JN; Johnston GA; Hinton T
Schizophr Res; 2007 Feb; 90(1-3):76-80. PubMed ID: 17208412
[TBL] [Abstract][Full Text] [Related]
17. Radioreceptor binding profile of the atypical antipsychotic olanzapine.
Bymaster FP; Calligaro DO; Falcone JF; Marsh RD; Moore NA; Tye NC; Seeman P; Wong DT
Neuropsychopharmacology; 1996 Feb; 14(2):87-96. PubMed ID: 8822531
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic olanzapine treatment on striatal synaptic organization.
Roberts RC
Synapse; 2001 Jan; 39(1):8-15. PubMed ID: 11071704
[TBL] [Abstract][Full Text] [Related]
19. Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment.
Minet-Ringuet J; Even PC; Valet P; Carpéné C; Visentin V; Prévot D; Daviaud D; Quignard-Boulange A; Tomé D; de Beaurepaire R
Mol Psychiatry; 2007 Jun; 12(6):562-71. PubMed ID: 17211438
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment.
Tarazi FI; Zhang K; Baldessarini RJ
J Pharmacol Exp Ther; 2001 May; 297(2):711-7. PubMed ID: 11303062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
